c-Myc Antibody (9E11) [DyLight 550] 0.1 ml

c-Myc NB200-108R

Contact Information

Choose a country to view pricing and purchasing information.

More on NB200-108R

  • c-Myc Primary Antibodies
  • All c-Myc Products
  • Alternate Names
     
  • Submit a Review

Ordering Information: NB200-108R

Catalog NumberNB200-108R
  • FormDyLight 550
  • Formats
  • Size(s)0.1 ml
  • Price, Shipping
    & Availability
     

     
  •  

c-Myc Antibody (9E11) [DyLight 550] Summary

 
Species Human, Mouse, Chicken, Yeast
Tested Applications WB, ChIP, IHC, IHC-Fr, IHC-P, IP
Clonality Monoclonal
Host Mouse
Gene MYC
Purity Protein A purified
Guarantee Plus All of our products are backed by our 100% guarantee to work for stated and predicted species and applications.
Innovator's Reward Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovator's Reward

c-Myc Antibody (9E11) [DyLight 550] Details

 
Format DyLight 550 (A=562, E=576)
Clone 9E11
Isotype IgG2a Kappa
Immunogen A synthetic peptide corresponding to amino acids 408-420 (AEEQKLISEEDL) of human c-Myc, conjugated to KLH. [UniProt# P01106]
Localization Nuclear

Species Reactivity

 
Human, mouse, Saccharomyces and chicken.

Applications/Dilutions

 
Dilutions
  • Western Blot 1:500-1:1000
  • Chromatin Immunoprecipitation 2 ug / 500 ug extract
  • Immunohistochemistry 1:100
  • Immunohistochemistry-Frozen 1:100
  • Immunohistochemistry-Paraffin 1:100
  • Immunoprecipitation 2ug/mg lysate
Application Notes

This c-Myc antibody (clone 9E11) is useful for Flow Cytometry, ChIP, Immunoprecipitation, ELISA, Immunohistochemistry- Frozen and Paraffin and Western blot.

Positive Controls

7 Positive Controls

Other Available
Formats
7C Labeled NB200-108V2
Allophycocyanin Labeled NB200-108APC
Biotin Labeled NB200-108B
DyLight 350 Labeled NB200-108UV
DyLight 405 Labeled NB200-108V
DyLight 405LS Labeled NB200-108V3
DyLight 488 Labeled NB200-108G
DyLight 650 Labeled NB200-108C
DyLight 680 Labeled NB200-108FR
DyLight 755 Labeled NB200-108IR
FITC Labeled NB200-108F
HRP Labeled NB200-108H
PE Labeled NB200-108PE
PerCP Labeled NB200-108PCP
Learn about Custom Antibody Labeling

Product PDFs

Reviews

Earn rewards points by submitting your review for c-Myc Antibody (NB200-108R).
Submit a Review

Publications

Earn rewards if you have published using c-Myc Antibody (NB200-108R).
Submit a Publication

Protocols and FAQs

Controls & Support Products

Research Tools

View all c-Myc Research Tools.

Packaging, Storage & Formulations

 
Storage Store at 4C in the dark.
Buffer 50 mM Sodium Borate
Unit Size 0.1 ml
Concentration 1.1 mg/ml
Preservative No Preservative
Limitations This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

 
Gene Symbol MYC
Entrez
Uniprot

Alternate Names for c-Myc

 
  • BHLHE39
  • Proto-oncogene c-Myc
  • myc-related translation/localization regulatory factor
  • Class E basic helix-loop-helix protein 39
  • myc proto-oncogene protein
  • v-myc avian myelocytomatosis viral oncogene homolog
  • avian myelocytomatosis viral oncogene homolog
  • c-Myc
  • bHLHe39MRTL
  • Transcription factor p64
  • v-myc myelocytomatosis viral oncogene homolog (avian)

Related Products by Gene

Background

 
The c-Myc protein is a transcription factor, which is encoded by the c-Myc gene on human chromosome 8q24. c-Myc is commonly activated in a variety of tumor cells and plays an important role in cellular proliferation, differentiation, apoptosis and cell cycle progression. The phosphorylation of c-Myc has been investigated and previous studies have suggested a functional association between phosphorylation at Thr58/Ser62 by glycogen synthase kinase 3, cyclin dependent kinase, ERK2 and C-Jun N terminal Kinase (JNK) in cell proliferation and cell cycle regulation. Studies also have shown that c-Myc is essential for tumor cell development in vasculogenesis and angiogenesis that distribute blood throughout the cells, and which brought extensive attention in the development of new therapeutic approach for cancer treatment.